Effect of single-dose, live, attenuated dengue vaccine in children with or without previous dengue on risk of subsequent, virologically confirmed dengue in Cebu, the Philippines: a longitudinal, prospective, population-based cohort study
Authors:
Open Access
- 22 March 2024
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 24 (7) , 737-745
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- World Health Organization
This publication has 21 references indexed in Scilit:
- Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling studyThe Lancet Infectious Diseases, 2022
- Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: A case-control studyVaccine, 2021
- Determining dengue virus serostatus by indirect IgG ELISA compared with focus reduction neutralisation test in children in Cebu, Philippines: a prospective population-based studyThe Lancet Global Health, 2020
- Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatusVaccine, 2020
- DengueThe Lancet, 2019
- Effect of Dengue Serostatus on Dengue Vaccine Safety and EfficacyNew England Journal of Medicine, 2018
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic DiseaseNew England Journal of Medicine, 2015
- DengueNew England Journal of Medicine, 2012
- From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccineVaccine, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007